Role of ECM and inflammatory remodeling in alcohol-induced liver and lung damage-diversity supplement
ECM和炎症重塑在酒精性肝肺损伤中的作用-多样性补充
基本信息
- 批准号:9121282
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-01 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAcute Lung InjuryAddressAlcohol abuseAlcohol consumptionAlcohol-Induced DisordersAlcoholic Liver DiseasesAlcoholsAnimalsCellsChronicClinicalDataDepositionDiseaseEndotoxemiaEpithelial CellsEthanolEventExtracellular MatrixFibrinFibrinolysisFunctional disorderGastrointestinal tract structureGenetic EngineeringGoalsHealthHepaticHepatotoxicityHypoxemiaIn SituIn VitroIncidenceIndividualInflammationInflammatoryInflammatory ResponseInjuryInterventionIntestinesInvestigationKupffer CellsLaboratoriesLeadLifeLinkLiverLungLung InflammationMediatingMediator of activation proteinModelingMorbidity - disease rateMusNicotinic ReceptorsOrganPeptide HydrolasesPlasminogen Activator Inhibitor 1PredispositionPreparationPulmonary EdemaRelative (related person)RiskRoleSeriesStructure of parenchyma of lungTestingTissuesTranslatingUp-RegulationWorkalcohol effectalcohol exposurealcohol responsebasein vivoliver inflammationliver injurylung injurymortalitynovelnovel therapeutic interventionnutritionproblem drinkerresponsetargeted treatment
项目摘要
DESCRIPTION (provided by applicant): The overarching theme of this project is to study the role of nutrition and gut flora/intestinal dysfunction on alcohol-induced organ injury. We will focus on two organs that are the most common victims of chronic alcohol abuse: liver and lung. Specifically, we will examine how alcohol activates tissue remodeling in liver and lung through the induction of plasminogen activator inhibitor-1 (PAI-1) and the consequences of these events. Novel in vitro and in vivo approaches will be used to address mechanisms of action with the goal of identifying new targets for intervention. We propose that liver and lung share similar mechanisms of organ damage in response to alcohol. We specifically propose that PAI-1 induction and subsequent extracellular matrix (ECM) remodeling are key to the early inflammatory changes in both organs. Considering observations linking the effects of alcohol on tissue remodeling in both organs, we further propose that liver and lung not only share mechanisms of injury in response to alcohol, but that these mechanisms are linked and represent interdependent events. Based on these observations and other preliminary data, this proposal will test the hypothesis that alcohol, through the activation of nicotinic acetylcholine receptors (nAChRs), induces the expression of PAI-1 in both liver (e.g., Kupffer cells) and lung (Type II epithelial cells). This, in turn, triggers a series of downstream events that promote live and lung injury in response to endotoxemia derived from the GI tract. Moreover, we propose that liver-derived mediators further exacerbate lung injury through the induction of inflammation and tissue remodeling enhanced by inhibition of fibrinolysis. These hypotheses will be tested in the following Specific Aims: Aim 1: To explore the role of PAI-1 and nAChRs in the susceptibility of liver and lung to acute injury observed in the setting of chronic alcohol exposure. We hypothesize that alcohol stimulates the expression of PAI-1 in both liver and lung cells through effects on specific nAChRs. This in turn sensitizes both organs to acute injury (e.g. LPS). Aim 2: To test the hypothesis that liver-derived mediators are involved in pulmonary changes caused by chronic alcohol exposure and LPS- related organ damage. We propose that alcohol-induced damage to the liver sensitizes the host to acute lung injury in at-risk individuals. To test this, e plan to evaluate the effects of alcohol on lung injury in animals with reduced hepatotoxicity using
genetically engineered and chimeric mice. Aim 3: To determine the role of gut- derived products on alcohol-induced lung damage. Gut changes/injury caused by alcohol consumption could directly or indirectly damage liver and lung tissue. However, how gut:lung or gut:liver:lung interactions are influenced by alcohol remains unknown. We propose to test these concepts, and to explore the effect of novel therapeutic interventions that target the GI tract to protect th lung.
描述(由申请人提供):本项目的首要主题是研究营养和肠道植物群/肠道功能障碍对酒精诱导的器官损伤的作用。我们将重点关注慢性酒精滥用最常见的两个器官:肝脏和肺。具体来说,我们将研究酒精如何激活组织重塑肝脏和肺通过诱导纤溶酶原激活物抑制剂-1(派-1)和这些事件的后果。新的体外和体内方法将用于解决行动机制,目的是确定新的干预目标。我们认为肝脏和肺在酒精引起的器官损伤中有相似的机制。我们特别提出派-1诱导和随后的细胞外基质(ECM)重塑是两个器官早期炎症变化的关键。考虑到酒精对这两个器官组织重塑影响的观察结果,我们进一步提出,肝脏和肺不仅有共同的酒精损伤机制,而且这些机制是相互关联的,代表着相互依存的事件。基于这些观察结果和其他初步数据,该提议将检验以下假设:酒精通过激活烟碱乙酰胆碱受体(nAChR)诱导两个肝脏中派-1的表达(例如,枯否细胞)和肺(II型上皮细胞)。这反过来又引发了一系列下游事件,这些事件促进了对源自胃肠道的内毒素血症的肝和肺损伤。此外,我们认为肝源性介质通过诱导炎症和抑制纤维蛋白溶解增强的组织重塑进一步加重肺损伤。这些假设将在以下具体目标中进行测试:目标1:探索派-1和nAChR在慢性酒精暴露环境中观察到的肝和肺对急性损伤的易感性中的作用。我们假设酒精通过对特定nAChRs的影响刺激肝脏和肺细胞中派-1的表达。这反过来又使两个器官对急性损伤(例如LPS)敏感。目标二:检验肝源性介质参与慢性酒精暴露和LPS相关器官损伤引起的肺变化的假设。我们认为,酒精引起的肝脏损伤使高危个体的宿主对急性肺损伤敏感。为了验证这一点,我们计划用肝毒性降低的动物来评估酒精对肺损伤的影响,
基因工程和嵌合小鼠。目的3:确定肠源性产物在酒精性肺损伤中的作用。饮酒引起的肠道变化/损伤可能直接或间接损害肝脏和肺组织。然而,肠:肺或肠:肝:肺的相互作用如何受到酒精的影响仍然未知。我们建议测试这些概念,并探索针对胃肠道保护肺的新型治疗干预措施的效果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gavin E Arteel其他文献
Gavin E Arteel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gavin E Arteel', 18)}}的其他基金
The role of matrix-bound microvesicles in alcohol-related liver disease
基质结合微泡在酒精相关性肝病中的作用
- 批准号:
10582800 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
肝移植后 NASH 纤维化的新型生物标志物
- 批准号:
10518842 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
肝移植后 NASH 纤维化的新型生物标志物
- 批准号:
10667657 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Liver-enriched Transcription Factors as Prognostic Markers and Therapeutic Targets in Alcoholic Hepatitis
肝脏富集转录因子作为酒精性肝炎的预后标志物和治疗靶点
- 批准号:
10428560 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Fellowship